
1. proc natl acad sci u a. 2012 apr 17;109(16):6235-40. doi:
10.1073/pnas.1203516109. epub 2012 apr 2.

gene selective mrna cleavage inhibits development plasmodium falciparum.

augagneur y(1), wesolowski d, tae hs, altman s, ben mamoun c.

author information: 
(1)department internal medicine, yale university school medicine, new
haven, ct 06510, usa.

unique peptide-morpholino oligomer (pmo) conjugates designed bind
and promote cleavage specific mrna tool inhibit gene function 
parasite growth. new conjugates validated using p. falciparum gyrase
mrna target (pfgyra). assays vitro demonstrated selective degradation
of pfgyra mrna directed external guide sequences, morpholino
oligomers conjugates. fluorescence microscopy revealed labeled
conjugates delivered plasmodium-infected erythrocytes all
intraerythrocytic stages parasite development. consistent expression 
of pfgyra stages parasite development, proliferation assays showed that
these conjugates potent antimalarial activity, blocking early development,
maturation, replication parasite. conjugates equally
effective drug sensitive resistant p. falciparum strains. the
potency, selectivity, predicted safety pmo conjugates make approach
attractive development unique class target-specific antimalarials
and large-scale functional analysis malarial genome.

doi: 10.1073/pnas.1203516109 
pmcid: pmc3341008
pmid: 22474358  [indexed medline]

